Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures

Epilepsia

Volumn 50, Issue 5, 2009, Pages 1141-1149

  Piñea Garza, Jesus Eric ^a   Nordli Jr, Douglas R ^b   Rating, Dietz ^c   Yang, Haichen ^d   Schiemann Delgado, Jimmy ^d   Duncan, Benjamin ^d  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UCB PHARMA   (Belgium)

Author keywords

Antiepileptic drug; Children; Epilepsy; Levetiracetam; Partial seizures

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; OXCARBAZEPINE; PHENOBARBITAL; PLACEBO; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CHILD; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; FOOD AVERSION; HUMAN; INFANT; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TREATMENT RESPONSE; URINARY TRACT INFECTION; VOMITING;

ANTICONVULSANTS; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; MALE; ODDS RATIO; PIRACETAM; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIDEOTAPE RECORDING;

EID: 65549121241     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01981.x     Document Type: Article

References (34)

1. Ben-Menachem E, Falter U 2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 41 : 1276 1283.
2. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U, Levetiracetam N01057 Study Group 2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69 : 1751 1760. (Pubitemid 350059304)
3. Boon P, Chauvel P, Pohlmann-Eden B, Otoul C, Wroe S 2002) Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy. Epilepsy Res 48 : 77 89. (Pubitemid 34127719)
4. Bourgeois BF 1995) Antiepileptic drugs in pediatric practice. Epilepsia 36 (Suppl. 2 S34 S45.
5. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ 2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68 : 402 408. (Pubitemid 46208740)
6. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I 2000) Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 55 : 236 242. (Pubitemid 30604624)
7. Clancy RR 1996) The contribution of EEG to the understanding of neonatal seizures. Epilepsia 37 (Suppl. 1 S52 S59. (Pubitemid 26181157)
8. Connell J, Oozeer R, de Vries L, Dubowitz LM, Dubowitz V 1989) Continuous EEG monitoring of neonatal seizures: diagnostic and prognostic considerations. Arch Dis Child 64 : 452 458. (Pubitemid 19105087)
9. Connock M, Frew E, Evans BW, Bryan S, Cummins C, Fry-Smith A, Li Wan Po A, Sandercock J 2006) The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review. Health Technol Assess 10 (7). Available at: http://www.hta.ac.uk/fullmono/mon1007.pdf. Accessed March 6, 2008. (Pubitemid 44334714)
10. Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, Nardello R, Habetswallner F, Licciardi F, Operto FF, Pascotto A 2004) Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 59 : 35 42. (Pubitemid 38595419)
11. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM 1999) Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A 96 : 15268 15273. (Pubitemid 30019801)
12. Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS 2007) Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res 74 : 60 69. (Pubitemid 46420762)
13. French J, Arrigo C 2005) Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 46 : 324 326. (Pubitemid 40194678)
14. Gidal BE, Baltès E, Otoul C, Perucca E 2005) Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Res 64 : 1 11. (Pubitemid 40726160)
15. Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group 2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66 : 1654 1660. (Pubitemid 43964617)
16. Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS 2007) Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 48 : 1117 1122. (Pubitemid 46854880)
17. Grosso S, Franzoni E, Coppola G, Iannetti P, Verrotti A, Cordelli DM, Marchiani V, Pascotto A, Spalice A, Acampora B, Morgese G, Balestri P 2005) Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14 : 248 253. (Pubitemid 40704329)
18. Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, Verrotti A, Morgese G, Balestri P 2007) Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy. Seizure 16 : 345 350. (Pubitemid 46620674)
19. Hauser WA 1992) Seizure disorders: the changes with age. Epilepsia 33 (Suppl. 4 S6 S14.
20. ILEA 1981) Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electrocephalographic classification of epileptic seizures. Epilepsia 22 : 489 501.
21. International Conference on Harmonisation Guideline for Good Clinical Practice [CPMP/ICH/135/95] (2002) ICH Topic E6 (R1) Guideline for good Clinical Practice. European Medicines Agency, London. Available at: http://www.emea. europa.eu/pdfs/human/ich/013595en.pdf. Accessed March 6, 2008.
22. Lagae L, Buyse G, Deconinck A, Ceulemans B 2003) Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol 7 : 123 128. (Pubitemid 36700750)
23. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B 2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 : 9861 9866. (Pubitemid 38869327)
24. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J, Levetiracetam N166 Study Group 2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70 : 607 616.
25. Otoul C, De Smedt H, Stockis A 2007) Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 48 : 2111 2115. (Pubitemid 350098756)
26. Patsalos PN 2004) Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 43 : 707 724. (Pubitemid 39159001)
27. Pellock JM, Appleton R 1999) Use of new antiepileptic drugs in the treatment of childhood epilepsy. Epilepsia 40 (Suppl. 6 S29 S38. (Pubitemid 29481920)
28. Pellock JM, Glauser TA, Bebin EM, Fountain NB, Ritter FJ, Coupez RM, Shields WD 2001) Pharmacokinetic study of levetiracetam in children. Epilepsia 42 : 1574 1579. (Pubitemid 34020096)
29. Perry MS, Benatar M 2007) Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia 48 : 1123 1127. (Pubitemid 46854864)
30. Perucca E, Gidal BE, Baltès E 2003) Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Res 53 : 47 56. (Pubitemid 36170170)
31. Piñea-Garza JE, Espinoza R, Nordli D, Bennett DA, Spirito S, Stites TE, Tang D, Sturm Y 2005) Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology 65 : 1370 1375. (Pubitemid 41552763)
32. Toublanc N, Sargentini-Maier M-L, Lacroix B, Jacqmin P, Stockis A 2008) Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations. Clin Pharmacokinet 47 : 333 341.
33. Weiner SP, Painter MJ, Geva D, Guthrie RD, Scher MS 1991) Neonatal seizures: electroclinical dissociation. Pediatr Neurol 7 : 363 368.
34. Wheless JW, Ng YT 2002) Levetiracetam in refractory pediatric epilepsy. J Child Neurol 17 : 413 415.